Jonathan Levin

703 total citations
19 papers, 416 citations indexed

About

Jonathan Levin is a scholar working on Economics and Econometrics, General Health Professions and Epidemiology. According to data from OpenAlex, Jonathan Levin has authored 19 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 8 papers in General Health Professions and 6 papers in Epidemiology. Recurrent topics in Jonathan Levin's work include Healthcare Policy and Management (7 papers), Primary Care and Health Outcomes (6 papers) and Substance Abuse Treatment and Outcomes (4 papers). Jonathan Levin is often cited by papers focused on Healthcare Policy and Management (7 papers), Primary Care and Health Outcomes (6 papers) and Substance Abuse Treatment and Outcomes (4 papers). Jonathan Levin collaborates with scholars based in United States and Philippines. Jonathan Levin's co-authors include Brendan Saloner, Liran Einav, Vilsa Curto, Amy Finkelstein, Jay Bhattacharya, G. Caleb Alexander, Christopher M. Jones, Hsien‐Yen Chang, Susan Athey and Adam S. Wilk and has published in prestigious journals such as American Journal of Preventive Medicine, Journal of Affective Disorders and Health Affairs.

In The Last Decade

Jonathan Levin

17 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Levin United States 8 193 145 130 94 55 19 416
Ingrid Mur‐Veeman Netherlands 13 122 0.6× 407 2.8× 73 0.6× 93 1.0× 18 0.3× 29 599
Arno van Raak Netherlands 14 117 0.6× 345 2.4× 49 0.4× 57 0.6× 20 0.4× 33 532
Pietro Giorgio Lovaglio Italy 13 106 0.5× 82 0.6× 54 0.4× 21 0.2× 37 0.7× 59 396
Zo Ramamonjiarivelo United States 12 100 0.5× 197 1.4× 52 0.4× 32 0.3× 15 0.3× 50 470
Hanna Augustsson Sweden 15 215 1.1× 411 2.8× 67 0.5× 11 0.1× 52 0.9× 41 637
Ties Hoomans Netherlands 10 203 1.1× 219 1.5× 67 0.5× 26 0.3× 14 0.3× 26 392
Ethan M.J. Lieber United States 10 162 0.8× 88 0.6× 96 0.7× 52 0.6× 5 0.1× 17 326
L. Maher Australia 2 68 0.4× 185 1.3× 48 0.4× 15 0.2× 22 0.4× 4 282
Martijn van Hasselt United States 12 188 1.0× 103 0.7× 43 0.3× 41 0.4× 15 0.3× 32 420
Carlo De Pietro Switzerland 10 118 0.6× 244 1.7× 75 0.6× 51 0.5× 6 0.1× 34 400

Countries citing papers authored by Jonathan Levin

Since Specialization
Citations

This map shows the geographic impact of Jonathan Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Levin more than expected).

Fields of papers citing papers by Jonathan Levin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Levin. The network helps show where Jonathan Levin may publish in the future.

Co-authorship network of co-authors of Jonathan Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Levin. A scholar is included among the top collaborators of Jonathan Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Levin. Jonathan Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Breslau, Joshua, et al.. (2024). Are disparities in mental health care for Medicaid beneficiaries lower in managed care?. Healthcare. 12(1). 100734–100734. 1 indexed citations
2.
Qureshi, Nabeel, et al.. (2024). Financial Interventions to Improve Screening in Primary Care: A Systematic Review. American Journal of Preventive Medicine. 67(1). 134–146. 1 indexed citations
3.
Levin, Jonathan, Xiaoxi Zhao, & Christopher Whaley. (2024). Impact of hospital‐physician vertical integration on physician‐administered drug spending and utilization. Health Economics. 34(2). 345–367. 2 indexed citations
4.
McBain, Ryan K., Jonathan Levin, Nabeel Qureshi, et al.. (2023). The effect of adverse childhood experience training, screening, and response in primary care: a systematic review. EClinicalMedicine. 65. 102282–102282. 10 indexed citations
5.
Levin, Jonathan, Brendan Saloner, Adam J. Gordon, et al.. (2022). Sociodemographic Differences in Quality of Treatment to Medicaid Enrollees Receiving Buprenorphine. Substance Abuse. 43(1). 1057–1071. 16 indexed citations
6.
Levin, Jonathan, et al.. (2022). Differences in buprenorphine treatment quality across physician provider specialties. Drug and Alcohol Dependence. 237. 109510–109510. 4 indexed citations
7.
Levin, Jonathan, et al.. (2022). Association between hospital‐physician vertical integration and medication adherence rates. Health Services Research. 58(2). 356–364. 6 indexed citations
8.
Levin, Jonathan, Joie Acosta, & Laura J. Faherty. (2022). New prescription fills of selective serotonin reuptake inhibitors before and during the COVID-19 pandemic in Los Angeles County, California. Journal of Affective Disorders. 319. 507–510. 5 indexed citations
9.
10.
Mulcahy, Andrew, et al.. (2021). Assessing Relationships Between Drug Shortages in the United States and Other Countries. RAND Corporation eBooks.
11.
Levin, Jonathan, Jeromie Ballreich, Mariana P. Socal, Ge Bai, & Geoffrey M. Anderson. (2019). PNS110 CONSOLIDATED DRUG PURCHASING ACROSS FEDERAL AGENCIES: A SOLUTION TO IMPROVE DRUG AFFORDABILITY IN MEDICARE PART D. Value in Health. 22. S303–S303. 1 indexed citations
12.
Kennedy‐Hendricks, Alene, Jonathan Levin, Elizabeth M. Stone, et al.. (2019). News Media Reporting On Medication Treatment For Opioid Use Disorder Amid The Opioid Epidemic. Health Affairs. 38(4). 643–651. 39 indexed citations
13.
DiStefano, Michael J. & Jonathan Levin. (2019). Does Incorporating Cost-Effectiveness Analysis Into Prescribing Decisions Promote Drug Access Equity?. The AMA Journal of Ethic. 21(8). E679–685. 5 indexed citations
14.
Saloner, Brendan, Adam S. Wilk, & Jonathan Levin. (2019). Community Health Centers and Access to Care Among Underserved Populations: A Synthesis Review. Medical Care Research and Review. 77(1). 3–18. 34 indexed citations
15.
Curto, Vilsa, Liran Einav, Amy Finkelstein, Jonathan Levin, & Jay Bhattacharya. (2019). Health Care Spending and Utilization in Public and Private Medicare. American Economic Journal Applied Economics. 11(2). 302–332. 93 indexed citations
16.
Minden, Sarah L., et al.. (2019). Use and cost of disease-modifying therapies by Sonya Slifka Study participants: has anything really changed since 2000 and 2009?. Multiple Sclerosis Journal - Experimental Translational and Clinical. 5(1). 2453240856–2453240856. 3 indexed citations
17.
Saloner, Brendan, Jonathan Levin, Hsien‐Yen Chang, Christopher M. Jones, & G. Caleb Alexander. (2018). Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion. JAMA Network Open. 1(4). e181588–e181588. 85 indexed citations
18.
Athey, Susan & Jonathan Levin. (2017). The value of information in monotone decision problems. Research in Economics. 72(1). 101–116. 24 indexed citations
19.
Levin, Jonathan. (2001). Information and the Market for Lemons. The RAND Journal of Economics. 32(4). 657–657. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ingrid Mur‐Veeman Breakdown of academic impact, for papers by Arno van Raak Breakdown of academic impact, for papers by Pietro Giorgio Lovaglio Breakdown of academic impact, for papers by Zo Ramamonjiarivelo Breakdown of academic impact, for papers by Hanna Augustsson Breakdown of academic impact, for papers by Ties Hoomans Breakdown of academic impact, for papers by Ethan M.J. Lieber Breakdown of academic impact, for papers by L. Maher Breakdown of academic impact, for papers by Martijn van Hasselt Breakdown of academic impact, for papers by Carlo De Pietro
Rankless by CCL
2026